These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 21991397

  • 1. Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study.
    Ostyn B, Gidwani K, Khanal B, Picado A, Chappuis F, Singh SP, Rijal S, Sundar S, Boelaert M.
    PLoS Negl Trop Dis; 2011 Oct; 5(10):e1284. PubMed ID: 21991397
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for visceral leishmaniasis and asymptomatic Leishmania donovani infection in India and Nepal.
    Picado A, Ostyn B, Singh SP, Uranw S, Hasker E, Rijal S, Sundar S, Boelaert M, Chappuis F.
    PLoS One; 2014 Oct; 9(1):e87641. PubMed ID: 24498159
    [Abstract] [Full Text] [Related]

  • 3. Latent infection with Leishmania donovani in highly endemic villages in Bihar, India.
    Hasker E, Kansal S, Malaviya P, Gidwani K, Picado A, Singh RP, Chourasia A, Singh AK, Shankar R, Menten J, Wilson ME, Boelaert M, Sundar S.
    PLoS Negl Trop Dis; 2013 Oct; 7(2):e2053. PubMed ID: 23459501
    [Abstract] [Full Text] [Related]

  • 4. Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study.
    Chakravarty J, Hasker E, Kansal S, Singh OP, Malaviya P, Singh AK, Chourasia A, Singh T, Sudarshan M, Singh AP, Singh B, Singh RP, Ostyn B, Fakiola M, Picado A, Menten J, Blackwell JM, Wilson ME, Sacks D, Boelaert M, Sundar S.
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007216. PubMed ID: 30917114
    [Abstract] [Full Text] [Related]

  • 5. Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal.
    Hasker E, Malaviya P, Gidwani K, Picado A, Ostyn B, Kansal S, Singh RP, Singh OP, Chourasia A, Kumar Singh A, Shankar R, Wilson ME, Khanal B, Rijal S, Boelaert M, Sundar S.
    PLoS Negl Trop Dis; 2014 Mar; 8(1):e2657. PubMed ID: 24466361
    [Abstract] [Full Text] [Related]

  • 6. Seropositivity of Visceral leishmaniasis on people of VL endemic three districts of Nepal.
    Basnyat S, Banjara MR, Ghimire P, Matlashewski G, Singh A.
    Parasitol Int; 2021 Feb; 80():102236. PubMed ID: 33147500
    [Abstract] [Full Text] [Related]

  • 7. Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes.
    Das VN, Siddiqui NA, Verma RB, Topno RK, Singh D, Das S, Ranjan A, Pandey K, Kumar N, Das P.
    Trans R Soc Trop Med Hyg; 2011 Nov; 105(11):661-6. PubMed ID: 21945327
    [Abstract] [Full Text] [Related]

  • 8. Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers.
    Das VNR, Bimal S, Siddiqui NA, Kumar A, Pandey K, Sinha SK, Topno RK, Mahentesh V, Singh AK, Lal CS, Singh SK, Das P.
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008272. PubMed ID: 32555598
    [Abstract] [Full Text] [Related]

  • 9. Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan.
    Khalil EA, Zijlstra EE, Kager PA, El Hassan AM.
    Trop Med Int Health; 2002 Jan; 7(1):35-44. PubMed ID: 11851953
    [Abstract] [Full Text] [Related]

  • 10. Usefulness of the direct agglutination test in the early detection of subclinical Leishmania donovani infection: a community-based study.
    Bimal S, Das VN, Sinha PK, Gupta AK, Verma N, Ranjan A, Singh SK, Sen A, Bhattacharya SK, Das P.
    Ann Trop Med Parasitol; 2005 Dec; 99(8):743-9. PubMed ID: 16297287
    [Abstract] [Full Text] [Related]

  • 11. Transmission of Leishmania donovani in the Hills of Eastern Nepal, an Outbreak Investigation in Okhaldhunga and Bhojpur Districts.
    Ostyn B, Uranw S, Bhattarai NR, Das ML, Rai K, Tersago K, Pokhrel Y, Durnez L, Marasini B, Van der Auwera G, Dujardin JC, Coosemans M, Argaw D, Boelaert M, Rijal S.
    PLoS Negl Trop Dis; 2015 Dec; 9(8):e0003966. PubMed ID: 26252494
    [Abstract] [Full Text] [Related]

  • 12. Spatial analysis of Leishmania donovani exposure in humans and domestic animals in a recent kala azar focus in Nepal.
    Khanal B, Picado A, Bhattarai NR, Van Der Auwera G, Das ML, Ostyn B, Davies CR, Boelaert M, Dujardin JC, Rijal S.
    Parasitology; 2010 Sep; 137(11):1597-603. PubMed ID: 20459877
    [Abstract] [Full Text] [Related]

  • 13. Serological markers for leishmania donovani infection in Nepal: Agreement between direct agglutination test and rK39 ELISA.
    Khanal B, Rijal S, Ostyn B, Picado A, Gidwani K, Menten J, Jacquet D, Lejon V, Chappuis F, Boelaert M.
    Trop Med Int Health; 2010 Nov; 15(11):1390-4. PubMed ID: 21998875
    [Abstract] [Full Text] [Related]

  • 14. Serological and Molecular Analysis of Leishmania Infection in Healthy Individuals from Two Districts of West Bengal, India, Endemic for Visceral Leishmaniasis.
    Kaushal H, Bhattacharya SK, Verma S, Salotra P.
    Am J Trop Med Hyg; 2017 Jun; 96(6):1448-1455. PubMed ID: 28719266
    [Abstract] [Full Text] [Related]

  • 15. Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors.
    Schenkel K, Rijal S, Koirala S, Koirala S, Vanlerberghe V, Van der Stuyft P, Gramiccia M, Boelaert M.
    Trop Med Int Health; 2006 Dec; 11(12):1792-9. PubMed ID: 17176343
    [Abstract] [Full Text] [Related]

  • 16. Molecular evidence supports the expansion of visceral leishmaniasis towards non-program districts of Nepal.
    Shrestha M, Khatri-Chhetri M, Poudel RC, Maharjan J, Dumre SP, Manandhar KD, Pandey BD, Pun SB, Pandey K.
    BMC Infect Dis; 2019 May 21; 19(1):444. PubMed ID: 31113385
    [Abstract] [Full Text] [Related]

  • 17. Detection of asymptomatic Leishmania infection in Bangladesh by antibody and antigen diagnostic tools shows an association with post-kala-azar dermal leishmaniasis (PKDL) patients.
    Owen SI, Hossain F, Ghosh P, Chowdhury R, Hossain MS, Jewell C, Cruz I, Picado A, Mondal D, Adams ER.
    Parasit Vectors; 2021 Feb 17; 14(1):111. PubMed ID: 33597000
    [Abstract] [Full Text] [Related]

  • 18. Significantly lower anti-Leishmania IgG responses in Sudanese versus Indian visceral leishmaniasis.
    Bhattacharyya T, Bowes DE, El-Safi S, Sundar S, Falconar AK, Singh OP, Kumar R, Ahmed O, Boelaert M, Miles MA.
    PLoS Negl Trop Dis; 2014 Feb 17; 8(2):e2675. PubMed ID: 24587456
    [Abstract] [Full Text] [Related]

  • 19. Validation of rK39 immunochromatographic test and direct agglutination test for the diagnosis of Mediterranean visceral leishmaniasis in Spain.
    Bangert M, Flores-Chávez MD, Llanes-Acevedo IP, Arcones C, Chicharro C, García E, Ortega S, Nieto J, Cruz I.
    PLoS Negl Trop Dis; 2018 Mar 17; 12(3):e0006277. PubMed ID: 29494596
    [Abstract] [Full Text] [Related]

  • 20. Persistence of Leishmania donovani antibodies in past visceral leishmaniasis cases in India.
    Gidwani K, Picado A, Ostyn B, Singh SP, Kumar R, Khanal B, Lejon V, Chappuis F, Boelaert M, Sundar S.
    Clin Vaccine Immunol; 2011 Feb 17; 18(2):346-8. PubMed ID: 21159922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.